Mumbai, July 27, 2017
Mumbai, July 27, 2017: More than half of the pharmaceutical and healthcare companies in India - multi-national and domestic - have a placeholder presence on digital platforms, and are failing to actively engage with their stakeholders, the ‘India Digital Health Report 2017’ by D Yellow Elephant, revealed on Wednesday.
The report analyzed 160 India based companies across 4 verticals – pharmaceuticals, medical devices & equipment, diagnostics and hospitals. The companies were studied on 12 key digital and social parameters - websites, apps, Facebook, Twitter, LinkedIn, YouTube, Google+, Blogger, Pinterest, Flickr, Instagram and Tumblr.
Based on presence, engagement, response, and consumer followership, companies are segregated into three categories – Digital Primes (the torch-bearers), Aspirants (gradually moving up on the digital curve) and Onlookers (silent observers).
Findings reveal that only 14% companies emerged as Digital Primes. 54% companies qualify as Digital Aspirants while the remaining 32% fall under the category of Digital Onlookers.
Of the four industry verticals, pharma accounts for the highest number of Digital Primes (22%). Medical devices & equipment and diagnostics have maximum Digital Aspirants, with 71% of the surveyed companies maintaining digital presence but lagging in engagement.
Apollo Diagnostics takes the overall top spot with a score of 70, followed by GE Healthcare with 65.5 and Pfizer with 65 points. Amongst hospitals, Kokilaben Dhirubhai Ambani Hospital leads with 56 points.
Mr. Aman Gupta, Managing Director, D Yellow Elephant, said, “The report indicates that pharmaceutical and healthcare companies in India are affected by ‘Engagement Draught’ - present across most social media platforms but reluctant to engage with stakeholders. With HCPs (Health Care Professionals), patients, caregivers and policymakers consuming bulk of information online, it is imperative for companies to develop a digital ecosystem spread across multiple channels.”
“Launched in 2015, the India Digital Health Report has set benchmarks for digital presence across the sector. The second edition reveals that the digital journey for most companies has started, but restricted to presence. A robust digital engagement strategy should be integral to the corporate strategy, rather than an afterthought,” he added.
LinkedIn enjoys the maximum presence with 91% players having a dedicated page, but only 11% companies actively engaging on the platform. Facebook is the second most preferred platform with 90% presence rate, followed by Twitter and YouTube.
Ms. Chandni Dalal, Lead, Digital Strategy, D Yellow Elephant said, “Out of the 160 companies surveyed, only 22 companies managed a score above 50 over a scale of 100 points. There is a trend of initiating and abandoning the platform midway, or selectively utilizing the medium, as and when the need arises. Patients now arrive in physicians’ offices armed with information, and their insistence on taking a more active role in their treatment is transforming healthcare from a provider dominated marketplace to a consumer-centred system. More education is needed at every level, and healthcare firms have a huge role to play in listening and informing both physicians and those they treat.”
The long-term aim of this report is to outline the digital integration required at all steps of a patient’s journey, from searching for symptomatic information, HCP interaction, diagnosis, treatment and follow ups.
The full report can be downloaded from www.dyellowelephant.com
D Yellow Elephant is a Full-service Digital & Social media firm, with a specialized focus on pharmaceuticals, medical technology, healthcare and wellness. Spread across key verticals of Digital & Social Analytics, Strategy, Design, Development and marketing. A part of The Strategic Partners Group, D Yellow Elephant represents the specialist brand focused on social and digital strategy service offerings.
With a global footprint in key locations of Delhi, Mumbai, Singapore, London and New York, the firm comes with a deep understanding of the Pharmaceuticals and Healthcare market, offering specialized services in HCP engagements, consumer communications and sales force empowerment.
As a full-service digital strategy powerhouse, DYE offers customized solutions to achieve business goals that can range from disease awareness, market shaping, market access, message amplification, brand development and digital marketing across an ecosystem that comprises of patient, HCP, caregivers, general population, policymakers, payers, and any other specific stakeholder using social and content strategy.
The firm comes armed with 20+ years of core Pharma and Lifesciences expertise, with a clear understanding of the legal and regulatory framework.
22 July 2015
New Delhi, July 22: Most pharmaceutical companies in India – both multi-nationals as well as domestic – are still shying away from leveraging the huge opportunities that exist on the digital platforms, a new study released by D Yellow Elephant www.dyellowelephant.com) on Wednesday revealed.
Titled ‘Indian Pharma Digital Health Report 2015’, this first-of-its-kind report analyzed as many as 40 pharmaceutical companies in India across 10 key digital parameters, ranging across websites, apps and 10 social media platforms, namely Twitter, Facebook, LinkedIn, YouTube, Google+, Instagram, Pinterest, Vine, Slideshare and Blogger.
The report has segregated all firms in key buckets of Digital Primes, Aspirants and Onlookers basis analyzes of presence, engagement, response, and consumer followership among few key parameters.
According to Mr. Aman Gupta, Managing Director of D Yellow Elephant, “The Pharmaceutical sector in India, whether Indian companies or global players, they are atleast 5-7 years lagging behing there global counterparts and if compared to other sectors, the time lag could go upto 10 years and above. Ironically, some of these same companies abroad are seen to be proactively using digital platforms to engage with health care professionals (HCPs) and patients,” he said, explaining that this report is an attempt to help the pharmaceutical sector entities in India catch up on the time gap, identify the loopholes and help them incorporate digital
medium in part of the decision making process.
Highlighting the key findings of the report, Ms. Chandni Dalal, Lead, Digital Strategy at D Yellow Elephant said, “Out of 40 companies surveyed, only 9 companies managed a score above 50 over a scale of 100 points. This shows the reluctance to effectively engage with their stakeholders on the digital platform.”
“The report is an attempt to underline the opportunities that exist and draw a roadmap for these pharmaceutical companies in India to engage better with the HCPs, and the patient community,” she said, that with the advent of smartphones across geographies, it is high time that the potential is realized. “What better way than effectively use these platforms to bridge the gap to healthcare access in a country like ours,” she explained.
According to Ms. Dalal, “Some of the results have been predictive with LinkedIn emerging as the most popular social media platform, with 95% presence; but only about 14 companies showing an active engagement. For their part, pharmaceutical companies in India are venturing on the digital highway, but basic building blocks like having an India specific website is still amiss.” About 30% of the companies still do not have an India Centric website.
In the age of quantified self, Indian patients and HCPs are exhibiting an expectations market, with the advent of digital health, big data and dialogue exchange; Indian pharma has long stayed behind the curve on social media.
The full report can be downloaded from www.dyellowelephant.com
D Yellow Elephant is a digital firm, focusing on the Pharmaceutical and Life-sciences industry offering specialized marketing communications services by integrating technology, medical sciences and communications. With a global footprint in key locations of Delhi, Mumbai, Singapore, London and New York, the firm comes with a deep understanding of the Pharmaceuticals and Healthcare market, offering specialized services in HCP engagements, consumer communications and sales force empowerment. D Yellow Elephant offers cutting-edge technical and development services like Holograms, virtual reality, gamification platforms, touch less interactions
and app developments.
31st March 2015
New Delhi/Mumbai: ‘D Yellow Elephant’ (www.dyellowelephant.com), a full service digital agency with a focus on pharmaceutical and healthcare industry initiated its India operations today. Led by a team with extensive experience in the Pharmaceuticals and Healthcare industry, ‘D Yellow Elephant’s’ mission is to create meaningful and measurable interactive web marketing for the world’s largest health & pharma brands and corporate.
The new firm counts 3 offices and approximately 20 staffers across the globe with operations in the United States, Europe and Asia.
The creation of D Yellow Elephant was spurred by the desire of the Aman Gupta, Co-Founder and one of the most respected names in pharmaceutical marketing, to build a truly global and integrated digital firm focused on delivering groundbreaking work in the Pharmaceuticals and Healthcare sector.
“D Yellow Elephant is an interaction firm, not a communication firm,” Said Aman Gupta.
He further added, “We have been the experts in Healthcare communications for more than 2 decades now and while digital communications have always been a part of overall structure, a need was felt to leverage our best capabilities through a medium which is bound to bring change in the coming future. D Yellow Elephant was created to respond to the need of specialized firm catering to Pharmaceuticals sector and fill in the gap with expert led, digitally oriented marketing ideas. With D Yellow Elephant, we can address not just advertising, but all points where consumers and brands come together, no matter what the channel or platform”
The firm spent a full year aligning the global services structure, company cultures and delivery model.
D Yellow Elephant develops solutions across a full range of digital media including mobile, web, television, out-of home, tablet, touch, online advertising and social media, bringing together technology and creativity in new ways that drive business growth and consumer interest.
About D Yellow Elephant:
D Yellow Elephant is a Full service Digital firm, with a specialized focus on Pharmaceutical and Healthcare Industry. The firm service offerings are spread across key verticals of Web Strategy, Design, Development and Information. D Yellow Elephant is focused on addressing the need for expert led healthcare communications designed to go beyond the traditional conventions to help engage the audience in a long lasting manner. Headquartered in India, with key offices in US and Singapore, D Yellow Elephant helps Pharma go beyond the Pill, with the Go Digital Philosophy.
For more information please contact: sonal@Dyellowelephant.com